Weekly CEO Buys Highlight

Insiders invest in Capri Holdings, General Electric, Sarepta Therapeutics, Ryman Hospitality Properties and Axogen

Author's Avatar
Aug 18, 2019
Article's Main Image

According to GuruFocus insider data, these are the largest CEO buys of the past week.

Capri Holdings CEO bought 363,000 shares

Capri Holdings Ltd. (CPRI, Financial) Chairman and CEO John D. Idol bought 363,000 shares on Aug. 15 for a price of $27.48. The share price has risen 2.77% since then.

Capri Holdings, formerly Michael Kors Holdings Ltd., designs and manufactures apparel, footwear and accessories (primarily handbags). Products are positioned as luxury goods and sold under three brands: Michael Kors, Versace and Jimmy Choo. The company has a market cap of $4.28 billion. Its shares traded at $28.24 with a price-earnings ratio of 10.64 as of Aug. 16.

Net income for the first quarter of fiscal 2020 was $45 million compared to $186 million in the prior-year quarter.

General Electric CEO bought 583,884 Shares

General Electric Co. (GE, Financial) Chairman and CEO H. Lawrence Culp Jr. bought 583,884 shares during the past week at an average price of $8.56.

General Electric is a diversified manufacturer that operates seven separate businesses in its industrial segment: power, oil and gas, renewable energy, lighting, aviation, health care and transportation. The company also provides specialty industrial financing through its GE Capital division. The company has a market cap of $76.71 billion. Its shares traded at a price of $8.79 as of Aug. 16.

Net loss was $61 million compared to net earnings of $615 million for the prior-year period.

Culp bought 331,684 shares on Aug. 12 at a price of $9.04 and 252,200 shares on Aug. 15 at a price of $7.93. The share price has increased by 10.84% since then.

Director Paula Rosput Reynolds bought 10,000 shares on Aug. 15 at a price of $8.53. The share price has increased by 3.05% since then.

Senior Vice President Scott Strazik bought 34,836 shares on Aug. 15 at a price of $8.01. The share price has risen 9.74% since then.

Senior Vice President L. Kevin Cox bought 105,600 shares on Aug. 13 at a price of $9.42. The share price has decreased by 6.69% since then.

Director Thomas W. Horton bought 55,248 shares on Aug. 12 at a price of $9.02. The share price has decreased by 2.55% since then.

Sarepta Therapeutics CEO bought 16,252 shares

Sarepta Therapeutics Inc. (SRPT, Financial) President and CEO Douglas S. Ingram bought 16,252 shares on Aug. 12 at a price of $123.07. Since then, the share price has increased by 1.53%.

Sarepta Therapeutics is a biotechnology company focused on treating rare, infectious and other diseases. The company has a market cap of $9.29 billion. Its shares traded at $124.95 as of Aug. 16.

The net loss for the second quarter of 2019 and 2018 was $276.4 million and $109.3 million, respectively.

Director Richard Barry bought 1,300 shares on Aug. 12 at a price of $122.5 and 3,700 shares on Aug. 14 at a price of $122.5. The share price has increased by 2% since then.

Ryman Hospitality Properties CEO bought 13,585 shares

Ryman Hospitality Properties Inc. (RHP, Financial) Chairman and CEO Colin V. Reed bought 13,585 shares on Aug. 9 at a price of $79.30. The share price has gained 2.75% since then.

Ryman Hospitality Properties is a real estate investment trust that focuses on group-oriented destination hotel assets in urban and resort markets in the United States. The company has a market cap of $4.19 billion. Its shares traded at $81.48 with a price-earnings ratio of 16.16 as of Aug. 16.

Net income for the second quarter was $49.38 million compared to $55.55 million for the prior-year quarter.

Axogen CEO bought 75,000 shares

Axogen Inc. (AXGN, Financial) CEO Karen L. Zaderej bought 75,000 shares on Aug. 9 at a price of $13.50. The price of the stock has increased by 13.48% since then.

AxoGen is a medical technology company. It provides products and education to improve surgical treatment algorithms for peripheral nerve injuries. The company has a market cap of $601.39 million. Its shares traded at $15.32 with a price-earnings ratio of 10.64 as of Aug. 16.

The net loss for the second quarter was $7 million compared to a net loss of $7.4 million in the year-ago quarter.

Chief Human Resources Officer Maria D. Martinez bought 2,000 shares on Aug. 14 at a price of $15.13. The share price has increased by 1.26% since then.

Chief Strategy and Business Development Officer Isabelle Billet bought 5,635 shares on Aug. 13 at the average price of $15.11. Since then, the price of the stock has increased by 1.39%.

Director Quentin S. Blackford bought 15,535 shares on Aug. 12 at a price of $14.01. The price of the stock has increased by 9.35% since then.

Director Mark Stephen Gold bought 4,000 shares on Aug. 9 at a price of $13.1. The price of the stock has increased by 16.95% since then.

For the complete list of stocks bought by their company CEOs, go to CEO Buys.

Disclosure: I do not own stock in any of the companies mentioned in the article.